Trials / Completed
CompletedNCT04810676
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-383 and Co-administration of CKD-501, D745, D150 Under Fed Condition in Healthy Adults.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-383.
Detailed description
A phase 1 clinical trial to evaluate pharmacokinetics and safety in healthy adult after oral administration of CKD-383 and co-administration of CKD-501, D745, D150.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-501, D745, D150 | QD, PO |
| DRUG | CKD-383 | QD, PO |
Timeline
- Start date
- 2021-04-16
- Primary completion
- 2021-05-20
- Completion
- 2021-05-26
- First posted
- 2021-03-23
- Last updated
- 2021-06-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04810676. Inclusion in this directory is not an endorsement.